from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1878/glnA3

LFCtreatmentdescriptionclass of inhibitor

0.421

Amikacinug/mL Amikacintranslation

2.106

Cap5-10ug/mL Capreomycintranslation

2.022

Rox10-50 ug/mL Roxithromycintranslation

-0.062

SM2-5 ug/mL Streptomycintranslation

1.139

Tet5-10 ug/mL Tetracyclinetranslation

0.019

Rif0.2-5ug/mL Rifampicintranscription

-0.290

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.760

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.038

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.334

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.771

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.393

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.219

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.118

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.254

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.219

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.298

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.913

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.279

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.501

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.266

Nigericin50 uM Nigericinrespiration

0.274

TRC10-150 ug/mL Triclosanrespiration

-0.870

TRZ10-25 ug/mL Thioridazinerespiration

-1.258

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-2.059

menadione6-10 ug/mL Menadionerespiration

0.180

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.375

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.207

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.021

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.852

NRP_1Non-replicating persistence stage 1dosRassociated

-0.284

Amp0.2mg/mL AmpicillincellWall

-0.312

Cephalexin20-100 ug/mL CephalexincellWall

-0.138

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.720

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.415

EMB10-20 ug/mL EthambutolcellWall

-0.250

Eta12-40 ug/mL EthionamidecellWall

-0.268

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.181

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.709

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.049

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.295

BZA0.12 mg/mL BenzamidearomaticAmides

0.389

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.369

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.296

H2O24 mM hydrogen peroxideDNAdamaging

-0.096

Levo10 ug/mL LevofloxacinDNAdamaging

0.446

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.366

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.234

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.198

UVUV-irradiationDNAdamaging

-0.215

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.024

Antimycin12.5-50 ug/mL Antimycin A?

-0.250

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.139

PA_110-50 ug/mL Antitubercular compound PA-1?

0.089

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.636

PA8240.2-2 ug/mL PA-824?

-0.879

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.166

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.361

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.189

methoxatin10-20 ug/mL Methoxatin?